アゼルニジピン
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/11/06 22:03:49」(JST)
[Wiki en表示]
Azelnidipine
|
Systematic (IUPAC) name |
O3-[1-[di(phenyl)methyl]azetidin-3-yl] O5-propan-2-yl 2-amino-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
Clinical data |
AHFS/Drugs.com |
International Drug Names |
Pregnancy cat. |
? |
Legal status |
℞ Prescription only |
Routes |
Oral |
Identifiers |
CAS number |
123524-52-7 N |
ATC code |
None |
PubChem |
CID 65948 |
ChemSpider |
59352 Y |
UNII |
PV23P19YUG Y |
KEGG |
D01145 Y |
Chemical data |
Formula |
C33H34N4O6 |
Mol. mass |
582.64 g/mol |
SMILES
- [O-][N+](=O)c1cccc(c1)C5C(/C(=O)OC(C)C)=C(\NC(\N)=C5\C(=O)OC4CN(C(c2ccccc2)c3ccccc3)C4)C
|
InChI
-
InChI=1S/C33H34N4O6/c1-20(2)42-32(38)27-21(3)35-31(34)29(28(27)24-15-10-16-25(17-24)37(40)41)33(39)43-26-18-36(19-26)30(22-11-6-4-7-12-22)23-13-8-5-9-14-23/h4-17,20,26,28,30,35H,18-19,34H2,1-3H3 Y
Key:ZKFQEACEUNWPMT-UHFFFAOYSA-N Y
|
N (what is this?) (verify)
|
Azelnidipine (INN; marketed under the brand name Calblock) is a dihydropyridine calcium channel blocker. It is sold in Japan by Daiichi-Sankyo pharmaceuticals, Inc. Unlike nicardipine, it has a gradual onset and has a long-lasting hypotensive effect, with little increase in heart rate.[1]
References[edit]
- ^ Oizumi K, Nishino H, Koike H, Sada T, Miyamoto M, Kimura T (September 1989). "Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker" ([dead link] – Scholar search). Jpn. J. Pharmacol. 51 (1): 57–64. doi:10.1254/jjp.51.57. PMID 2810942.
Channel blockers
|
|
Calcium (Ca2+) |
|
|
Potassium (K+) |
- 3,4-Diaminopyridine
- 4-Aminopyridine
- Amiodarone
- Bretylium
- Bunaftine
- Charybdotoxin
- Conotoxins
- Dofetilide
- Dronedarone
- E-4031
- Ibutilide
- Linopirdine
- Maurotoxin
- Nifekalant
- Paxilline
- Sotalol
- Tedisamil
- Tetraethylammonium
- Vernakalant
|
|
Sodium (Na+) |
- Antiarrhythmics: Ajmaline
- Aprindine
- Disopyramide
- Dronedarone
- Encainide
- Flecainide
- Lidocaine
- Lorajmine
- Lorcainide
- Mexiletine
- Moricizine
- Phenytoin
- Pilsicainide
- Prajmaline
- Procainamide
- Propafenone
- Quinidine
- Sparteine
- Tocainide
- Anticonvulsants: Carbamazepine
- Eslicarbazepine acetate
- Ethotoin
- Fosphenytoin
- Licarbazepine
- Mephenytoin
- Oxcarbazepine
- Oxitriptyline
- Phenytoin
- Rufinamide
- Topiramate
- Sodium valproate
- Valnoctamide
- Valproate pivoxil
- Valproate semisodium
- Valproic acid
- Valpromide
- Diuretics: Amiloride
- Benzamil
- Triamterene
- Local anesthetics: pFBT
- Amylocaine
- Articaine
- Benzocaine
- Bupivacaine (Levobupivacaine, Ropivacaine)
- Butacaine
- Butamben
- Chloroprocaine
- Cinchocaine
- Cocaine
- Cyclomethycaine
- Dimethocaine
- Etidocaine
- Hexylcaine
- Iontocaine
- Lidocaine
- Mepivacaine
- Meprylcaine
- Metabutoxycaine
- Orthocaine
- Piperocaine
- Prilocaine
- Procaine
- Propoxycaine
- Proxymetacaine
- Risocaine
- Tetracaine
- Trimecaine
- Toxins: Conotoxins
- Neosaxitoxin
- Saxitoxin
- Tetrodotoxin
|
|
Other |
- Uncategorized: Ethadione
- Paramethadione
- Phenacemide
- Pheneturide
- Trimethadione
|
|
English Journal
- Clinical study with azelnidipine in patients with essential hypertension. Antiarteriosclerotic and cardiac hypertrophy-inhibitory effects and influence on autonomic nervous activity.
- Nada T1, Nomura M, Koshiba K, Kawano T, Mikawa J, Ito S.
- Arzneimittel-Forschung.Arzneimittelforschung.2007;57(11):698-704. doi: 10.1055/s-0031-1296670.
- A dihydropyridine calcium (Ca) antagonist, azelnidipine (CAS 123524-52-7, Calblock), exhibits hypotensive effects for a prolonged duration, and has been reported to have a strong antiarteriosclerotic action due to its high affinity for vascular tissues and antioxidative action. It has also been repo
- PMID 18193691
- Simultaneous determination of azelnidipine and two metabolites in human plasma using liquid chromatography-tandem mass spectrometry.
- Kawabata K1, Urasaki Y.
- Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.J Chromatogr B Analyt Technol Biomed Life Sci.2006 Nov 21;844(1):45-52. Epub 2006 Jul 18.
- A quantitative assay method by liquid chromatography/electrospray ionization-tandem mass spectrometry (LC/ESI-MS/MS) for the simultaneous determination of azelnidipine and its two metabolites, M-1 (aromatized form) and M-2 (hydroxylated form), in human plasma was developed and validated. Plasma samp
- PMID 16854634
- Pharmacological profiles and clinical effects of azelnidipine, a long-acting calcium channel blocker.
- Sada T1, Saito H.
- Nihon yakurigaku zasshi. Folia pharmacologica Japonica.Nihon Yakurigaku Zasshi.2003 Dec;122(6):539-47.
- Azelnidipine (Calblock) is a newly developed dihydropyridine-type calcium antagonist for the treatment of hypertension. In hypertensive animals, a single oral administration of azelnidipine caused a slowly developed and long-lasting hypotensive effect with a little reflex tachycardia. The extent of
- PMID 14639008
Japanese Journal
- Effect of a Single Glass of Grapefruit Juice on the Apparent Oral Bioavailability of the Dihydropyridine Calcium Channel Antagonist, Azelnidipine, in Healthy Japanese Volunteers
- 臨床薬理 = JAPANESE JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 37(3), 127-133, 2006-05-31
- NAID 10019168973
- 持続型カルシウム拮抗薬アゼルニジピン(カルブロック^【○!R】)の薬理特性と臨床効果
- 日本薬理学雑誌 : FOLIA PHARMACOLOGICA JAPONICA 122(6), 539-547, 2003-12-01
- NAID 10013680035
Related Links
- CALBLOCK TABLETS 承認番号等 承認番号 21500AMZ00031 販売開始年月 2003年 5月 貯法・有効期間 貯法 室温保存 有効期間 3年 基準名 日本薬局方 アゼルニジピン錠 規制区分 処方箋医薬品 注 2) 注 2) 注意―医師等の処方箋に ...
- 第一三共の「カルブロック錠8mg、16mg」の製品情報。「カルブロック錠8mg、16mg」の禁忌、効能・効果、用法・用量、副作用、添付文書などの主な基本情報から、取り扱い注意事項やお知らせ情報まで、「Medical Library(メディカルライブラリー)」でご覧いただけます。
- CALBLOCK TABLETS 第一三共 2149043F1020 27.1円/錠 処方箋医薬品 注) カルブロック錠16mg CALBLOCK TABLETS 第一三共 2149043F2026 48.4円/錠 処方箋医薬品 注) 2. 禁忌 次の患者には投与しないこと 2.1 妊婦又は ...
Related Pictures
★リンクテーブル★
[★]
- 英
- azelnidipine
- 商
- カルブロック Calblock、レザルタス配合
- 関
- 血圧降下剤